Antibiotics modulate vaccine-induced humoral immune response

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 832-837

  Woo, Patrick C Y ^a   Tsoi, Hoi Wah ^a   Wong, Lei Po ^a   Leung, Harry C H ^a   Yuen, Kwok Yung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; DOXYCYCLINE; GAMMA INTERFERON; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; MACROLIDE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TETRACYCLINE DERIVATIVE; TYPHOID VACCINE; VACCINE;

ANIMAL EXPERIMENT; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; FEMALE; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VACCINATION;

EID: 0032706712     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.832-837.1999     Document Type: Article

References (27)

1. Barnes, P. J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14:436-441.
2. Bellahsene, A., and A. Forsgren. 1985. Effect of doxycycline on immune response in mice. Infect. Immun. 48:556-559.
3. Blake, P. A., D. M. Musher, J. E. Groover, R. A. Feldman, and T. M. Buchanan. 1976. Serologic therapy of tetanus in the United States. JAMA 235:42-44.
4. 3H-Staphylococcus aureus by human macrophages. Microbios 58:17-25.
5. Clerici, M., and G. M. Shearer. 1990. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. J. Immunol. 144:2480-2486.
6. Cuffini, A. M., N. A. Carlone, V. Tullio, and M. Borsotto. 1989. Comparative effects of roxithromycin and erythromcyin on cellular immune functions in vitro. 3. Killing of intracellular Staphylococcus aureus by human macrophages. Microbios 58:27-33.
7. Fujii, T., J. Kadota, K. Kawakami, K. Iida, R. Shirai, M. Kaseda, S. Kawamoto, and S. Kohno. 1995. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50:1246-1252.
8. Germanier, R., and E. Furer. 1975. Isolation and characterization of GalE mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131:553-558.
9. Giammarco, R., M. T. Lun, G. Luorino, C. Nazzari, A. Gaeta, C. Mancini, and F. Filadoro. 1993. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. J. Antimicrob. Chemother. 31:117-128.
10. Hamill, R. J., D. M. Musher, J. E. Groover, P. J. Zavell, and D. A. Watson. 1992. IgG antibody reactive with five Streptococcus pneumoniae serotypes in commercial intravenous immunoglobulin preparations and relationship to mouse protection. J. Infect. Dis. 166:38-42.
11. Keicho, N., S. Kudoh, H. Yotsumoto, and S. Akagawa. 1994. Erythromycin promotes monocyte to macrophage differentiation. J. Antibiot. 47:80-89.
12. Markham, R. B., P. W. Stashak, B. Prescott, D. F. Amsbaugh, and P. J. Baker. 1978. Selective sensitivity to hydrocortisone of regulatory functions that determine the magnitude of the antibody response to type III pneumococcal polysaccharide. J. Immunol. 121:829-834.
13. Milano, S., F. Arcoleo, P. D'Agostino, and E. Cillari. 1997. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob. Agents Chemother. 41:117-121.
14. Miyatake, H., F. Taki, H. Taniguchi, R. Suzuki, K. Takagi, and T. Satake. 1991. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99:670-673.
15. Morikawa, K., F. Oseko, S. Morikawa, and K. Iwamoto. 1994 Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. Antimicrob. Agents Chemother. 38:2643-2647.
16. Musher, D. M., B. Johnson, Jr., and D. A. Watson. 1990. Quantitative-relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect. Immun. 58: 3871-3876.
17. Nagai, H., H. Shishido, R. Yoneda, E. Yamaguchi, A. Tamura, and A. Kurashima. 1991. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 58:145-149.
18. Ritts, R. E. 1990. Antibiotics as biological response modifiers. J. Antimicrob. Chemother. 26(Suppl. C):31-36.
19. Shapira, L., W. A. Soskolne, Y. Houri, V. Barak, A. Halabi, and A. Stabholz. 1996. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracyclinc: correlation with inhibition of cytokine secretion. Infect. Immun. 64:825-828.
20. Simanjuntak, C. H., F. P. Paleolog, N. H. Punjabi, R. Darmowigoto, Soeprawoto, H. Totosudirjo, P. Haryanto, E. Suprijanto, N. D. Witham, and S. L. Hoffman. 1991. Oral immunization against typhoid fever in Indonesia with Ty21a vaccine. Lancet 338:1055-1059.
21. Szmuness, W., C. E. Stevens, and F. A. Zang. 1982. A controlled trial on the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1:377-385.
22. Takeshita, K., I. Yamagishi, and M. Harada. 1989. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production by murine peritoneal macrophages. Drugs Exp. Clin. Res. 15:527-533.
23. Valtonen, M. V., and P. Häyry. 1978. O antigen as virulence factor in mouse typhoid: effect of B-cell suppression. Infect. Immun. 19:26-28.
24. Wahdan, M. H., C. Serie, Y. Ceriser, S. Sallam, and R. Germanier. 1982. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three year results. J. Infect. Dis. 145:292-295.
25. Webster, G. F., S. M. Toso, and L. Hegemann. 1994. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C. Arch. Dermatol. 130:748-752.
26. Woo, P. C. Y., L. W. C. Chow, E. S. K. Ma, and K. Y. Yuen. 1999. Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. Pharmacol. Res. 39:49-54.
27. Woo, P. C. Y., W. F. Ng, H. C. H. Leung, H. W. Tsoi, K. Y. Yuen. Clarithromycin attenuates cyclophosphamide-induced mucositis in mice. Pharmacol. Res., in press.